A glucagon analogue decreases body weight in mice via signalling in the liver. (2021)

First Author: Hinds CE
Attributed to:  Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-021-01912-0

PubMed Identifier: 34799628

Publication URI: http://europepmc.org/abstract/MED/34799628

Type: Journal Article/Review

Volume: 11

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322